Nail outcome improvements with certolizumab pegol in moderate to severe plaque psoriasis: results from phase 3 trials

被引：0

作者：

Gottlieb, A. B. ^{[1
]}

Thaci, D. ^{[2
]}

Leonardi, C. ^{[3
,4
]}

Poulin, Y. ^{[5
]}

Kavanagh, S. ^{[6
]}

Boehnlein, M. ^{[7
]}

Reich, K. ^{[8
,9
]}

机构：

[1] Icahn Sch Med Mt Sinai, New York, NY 10029 USA

[2] Univ Lubeck, Lubeck, Germany

[3] Cent Dermatol, St Louis, MO USA

[4] St Louis Univ, Sch Med, St Louis, MO USA

[5] Ctr Rech Dermatol Quebec Metropolitain, Quebec City, PQ, Canada

[6] UCB Pharma, Raleigh, NC USA

[7] UCB Pharma, Monheim, Germany

[8] SCIderm Res Inst, Hamburg, Germany

[9] Dermatologikum Berlin, Berlin, Germany

来源：

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2019年 / 33卷

关键词：

Certolizumab Pegol; Nail disease; Psoriasis;

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

P116

引用

页码：54 / 54

页数：1

共 3 条

[1] Validity of the rheumatoid arthritis MRI score applied to the forefeet using the OMERACT filter: a systematic literature review [J].

Dakkak, Yousra J. ;

van der Heijde, Desiree M. ;

Reijnierse, Monique ;

van der Helm-van Mil, Annette H. M. .

RMD OPEN, 2018, 4 (02)

[2] Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks from 2 phase 3, multicenter, randomized, double-blinded, placebo-controlled studies (CIMPASI-1 and CIMPASI-2) [J].

Gottlieb, Alice B. ;

Blauvelt, Andrew ;

Thaci, Diamant ;

Leonardi, Craig L. ;

Poulin, Yves ;

Drew, Janice ;

Peterson, Luke ;

Arendt, Catherine ;

Burge, Daniel ;

Reich, Kristian .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (02) :302-+

[3]

Lebwohl M, 2018, J AM ACAD DERMATOL, V79

← 1 →